NCT02993315View on ClinicalTrials.gov

Melanoma Patients Immunized with Natural DenDritic Cells

PHASE3CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

January 31, 2024

Study Completion Date

May 31, 2024

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

nDC vaccination

BIOLOGICAL

placebo injection

Trial Locations (5)

Unknown

NKI-AvL, Amsterdam

VUmc, Amsterdam

Radboudumc, Nijmegen

ErasmusMC, Rotterdam

Isala klinieken, Zwolle

All Listed Sponsors
collaborator

Dutch National Health Care Institute

OTHER

collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Radboud University Medical Center

OTHER

NCT02993315 - Melanoma Patients Immunized with Natural DenDritic Cells | Biotech Hunter | Biotech Hunter